LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2-Reference-Cited by-同舟云学术

LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2

Published:2017-09-29 Issue:11 Volume:69 Page:867-876
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Wang Zhi¹^ORCID,Tan Meiyun¹,Chen Ge¹,Li Zhong¹,Lu Xiaobo¹

Affiliation:

1. Department of Bone and Joint Surgery; The Affiliated Hospital of Southwest Medical University; Luzhou Sichuan People's Republic of China

Funder

Science and Technology Department

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Reference35 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Primary bone osteosarcoma in the pediatric age: state of the art;Longhi;Cancer Treat. Rev.,2006

3. Cancer statistics in China, 2015;Chen;CA Cancer J. Clin.,2016

4. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017

5. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols;Kager;J. Clin. Oncol.,2003

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy;Life Sciences;2024-05

2. AMPFLDAP: Adaptive Message Passing and Feature Fusion on Heterogeneous Network for LncRNA-Disease Associations Prediction;Interdisciplinary Sciences: Computational Life Sciences;2024-04-06

3. Emerging roles of long non-coding RNAs in osteosarcoma;Frontiers in Molecular Biosciences;2024-03-07

4. The impact of LncRNA-SOX2-OT/let-7c-3p/SKP2 Axis on head and neck squamous cell carcinoma progression: Insights from bioinformatics analysis and experimental validation;Cellular Signalling;2024-03

5. Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation;Medical Oncology;2023-07-28